Whether it be the original ‘Rule of 7’or more recent studies that suggest the new number is much higher in the digital age we now live in, the premise remains that increasing message frequency can have a significant impact on retention and driving behaviour change, but does this theory extend to doctors? Let’s start with
A leading prescription brand had lost market share following negative publicity. With local key opinion leaders questioning the brand’s efficacy, both medical and consumer media were running hard with the story – eroding prescriber and patient trust. The client needed a powerful tool to support its omnichannel response and quickly turn this around.
Building an opted-in HCP database and attracting HCPs to sign up to microsites is an ongoing challenge for pharmaceutical companies. This campaign illustrates the cost effectiveness of digital engagement solutions such as Access.PLUS to successfully drive APHRA-verified HCP sign-ups.
Black Dog Institute, a leading university-based mental health research institute asked ADG to promote its Working Towards Wellbeing training video series. The aim was to encourage best-practice mental health treatment options.
A leading pharmaceutical company asked ADG to design a campaign encouraging GPs to follow updated treatment guidelines and build their knowledge and confidence to initiate prescriptions of its product.
Meet John Betsis from the Gold Coast, diagnosed with mitochondrial disease in his late teens.
Hologic tasked ADG to promote its leading gynaecological product to help close knowledge gaps among GPs and address both over and undertreatment for heavy menstrual bleeding.
A leading brand in the Women’s Health market tasked ADG to deliver growth and maintain profitability of the brand through a digital only plan. GPs who engaged in 4 or more Access.PLUS articles had a 14% higher prescription rate vs the market and non-engaged GPs.
The Royal College of Pathologists of Australasia (RCPA), with funding from the Australian Government Department of Health, partnered with ADG to help promote the quality use of pathology to GPs and other health professionals.
A leading brand in the type 1 and type 2 diabetes market asked ADG to support the launch of a new product. The campaign resulted a 3-fold increase in scripts among eDetailed GPs.
A chronic insomnia brand tasked ADG to help them challenge the way GPs think about the diagnosis and treatment of insomnia and to drive the launch of new science (a sleep/wake system) and treatment options. Within the first two weeks of launch 1,740 GPs had viewed the brand eDetails.
